ABBV-RGX-314

AbbVie and Regenxbio’s ‘multibillion-dollar opportunity’ in vision loss gene therapy
Pharma Voice
Wed, 04/24/24 - 08:42 am
Regenxbio
AbbVie
gene therapy
ABBV-RGX-314
wet age-related macular degeneration
diabetic retinopathy
Regenxbio unveils positive data from diabetic retinopathy therapy trial
Clinical Trials Arena
Mon, 11/6/23 - 11:27 am
Regenxbio
clinical trials
ABBV-RGX-314
diabetic retinopathy